(RTTNews) - Arvinas Inc. (ARVN), a clinical-stage biotechnology company, Friday announced promising first-in-human data for ARV-102, an investigational oral PROTAC designed to target and degrade ...

For over 20 years, Rwanda has relied on foreign donors to provide free Antiretroviral (ARV) treatment to its population living with HIV, but now, experts believe the reliance should gradually ...